1 not yet recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Lymphoma, T Cell, Peripheral: new trials by email Literature Review of Lymphoma, T Cell, Peripheral trials Research Report on Lymphoma, T Cell, Peripheral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Cell Therapy in Refractory T-Cell Lymphoma Baseline FDG-PET/CT, First-line chemotherapy, Interim FDG-PET/CT after two cycles of first-line chemotherapy - Lymphoma, T Cell, Peripheral | Phase 2 | Not yet recruiting | University Medical Center Goettingen | 70 | 2026-11-01 | 2026-11-05 |
| Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma azacitidine, abatacept - Lymphoma, T Cell, Peripheral, T-cell Lymphoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 20 | 2026-03-26 | 2026-10-20 |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors ASN002 Dose Escalation, ASN002 RD - Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell | Phase 1 / Phase 2 | Terminated | Asana BioSciences | 51 | 2015-05-01 | 2023-06-07 |
Lymphoma, T-Cell, Peripheral (3) · Immunoblastic Lymphadenopathy (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Neoplasms (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell (2) · Neoplasms (2) · Bone Marrow Diseases (1) · Chronic Disease (1)
Abatacept (1) · Azacitidine (1)
Asana BioSciences (1) · National Cancer Institute (NCI) (1) · University Medical Center Goettingen (1)
United States (2) · Argentina (1)
Gerald Wulf, Prof. Dr. med. (1) · Niranjan Rao, PhD (1) · Samuel Y Ng, M.D. (1)